Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

The readout, representing a May 28 data cut from two patients with immune-mediated necrotizing myopathy and SLE, indicated a well-tolerated safety profile with no serious adverse events ...